New poll shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs if they are struggling with obesity ...
Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as GLP-1 receptor agonists, including the popular name brands Ozempic, Wegovy, ...
CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...
The offerings reflect an increase in IPO activity that could continue, as four other biotechs recently outlined plans to go ...
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
BBC Good Food on MSN1d
Weight loss drugs – are they right for you?Find out all you need to know about Ozempic and other weight loss drugs, including the dangers and side effects ...
Versant Ventures continues to invest in the increasingly competitive obesity space, this time launching Helicore with $65 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback